• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

Recent Advances in the Application of 4-Bromo-3-chloro-5-nitropyridine (CAS: 1072141-30-0) in Chemical Biology and Pharmaceutical Research

The compound 4-Bromo-3-chloro-5-nitropyridine (CAS: 1072141-30-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile reactivity and potential applications in drug discovery and development. This heteroaromatic compound serves as a key intermediate in the synthesis of various pharmacologically active molecules, particularly those targeting infectious diseases and cancer. Recent studies have explored its utility in cross-coupling reactions, nucleophilic substitutions, and as a precursor for more complex nitrogen-containing heterocycles.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the effectiveness of 4-Bromo-3-chloro-5-nitropyridine as a building block for novel kinase inhibitors. The research team utilized this compound in a palladium-catalyzed Suzuki-Miyaura coupling reaction to generate a series of pyridine-based compounds with potent inhibitory activity against EGFR and HER2 kinases. The electron-withdrawing properties of the nitro and halogen groups at the 3, 4, and 5 positions were found to significantly influence the electronic characteristics of the resulting molecules, affecting their binding affinity and selectivity.

In antimicrobial research, 4-Bromo-3-chloro-5-nitropyridine has shown promise as a precursor for developing new antibacterial agents. A recent publication in Bioorganic & Medicinal Chemistry Letters (2024) described its transformation into various 5-aminopyridine derivatives through reduction and subsequent functionalization. These derivatives exhibited notable activity against drug-resistant strains of Staphylococcus aureus, with minimum inhibitory concentrations (MICs) in the range of 2-8 μg/mL. The presence of both bromo and chloro substituents was crucial for maintaining the compounds' stability under physiological conditions while allowing for further structural modifications.

The compound's role in materials science has also been explored, particularly in the development of organic electronic materials. Researchers at several institutions have investigated 4-Bromo-3-chloro-5-nitropyridine as a precursor for nitrogen-doped graphene analogs and as a component in organic semiconductors. Its ability to undergo both nucleophilic aromatic substitution and metal-catalyzed coupling reactions makes it particularly valuable for creating π-conjugated systems with tailored electronic properties.

From a synthetic chemistry perspective, recent advances have focused on developing more efficient and sustainable methods for producing and functionalizing 4-Bromo-3-chloro-5-nitropyridine. A 2023 Green Chemistry publication highlighted a novel continuous-flow process that reduces the environmental impact of its synthesis while improving yield and purity. This development is particularly important given the growing demand for this intermediate in pharmaceutical manufacturing.

In conclusion, 4-Bromo-3-chloro-5-nitropyridine (CAS: 1072141-30-0) continues to be a valuable scaffold in multiple areas of chemical and pharmaceutical research. Its unique combination of reactivity and structural features enables the creation of diverse molecular architectures with potential therapeutic applications. Ongoing research is expected to further expand its utility, particularly in the development of targeted therapies and advanced materials.

• 75806-86-9(2-Bromo-5-chloro-3-nitropyridine)
• 1946807-79-9(4-Bromo-5-chloro-3-nitropyridin-2-amine)
• 1806051-27-3(4-Bromo-5-chloro-2-methyl-3-nitropyridine)
• 1805577-01-8(4-Bromo-3-chloro-2-methyl-5-nitropyridine)
• 1261767-18-3(4-Bromo-2-chloro-5-nitropyridine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)